Thermo Fisher Scientific (TMO) Invested Capital (2009 - 2026)

Thermo Fisher Scientific has reported Invested Capital for 18 years, with the latest figure at $3.4 billion in Q2 2026.

• Invested Capital for Q2 2026 came in at $3.4 billion, up 52.12% year-over-year; the trailing twelve-month figure through Jun 2026 was $13.8 billion (up 21.57% YoY), and the FY2025 annual result was $3.5 billion, up 59.58% from the prior year.
• Invested Capital rose to $3.4 billion in Q2 2026, from $3.1 billion in the prior quarter.
• Over five years, Invested Capital peaked at $6.1 billion in Q2 2023 and troughed at $1.0 billion in Q3 2022.
• A 5-year average of $3.5 billion and a median of $3.6 billion in 2023 frame the typical range for Invested Capital.
• The widest annual swing landed in 2022, when Invested Capital jumped 46550.0%; it then slumped 56.77% in 2025.
• A 5-year view of Invested Capital shows it stood at $5.6 billion in 2022, then sank by 35.31% to $3.6 billion in 2023, then plunged by 38.65% to $2.2 billion in 2024, then soared by 59.58% to $3.5 billion in 2025, then slipped by 4.67% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $3.4 billion in Q2 2026, $3.1 billion in Q1 2026, and $3.5 billion in Q4 2025.